Viral Infections in Hematopoietic Stem Cell Transplant and Cellular Therapy Recipients
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Human Virology and Viral Diseases".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 990
Special Issue Editor
Interests: management and prevention of infectious complications in cancer patients, particularly those undergoing hematopoietic cell transplantation and cellular therapy; viral and fungal infections
Special Issue Information
Dear Colleagues,
The field of hematopoietic stem cell transplantation is constantly evolving, with changing practices relating to conditioning chemotherapy in order to prepare patients to receive cellular therapy. Moreover, there are changes in the prophylaxis against graft versus host disease (GVHD), for example, an increasing use of post-transplant treatment with cyclophosphamide. These factors play an important role in the risk of infection with opportunistic pathogens, particularly viral infections.
In this Special Issue, the goal is to have updates from experts in the field relating to certain DNA viruses and respiratory viral infections. This will include reviews on infections caused by pathogens such as cytomegalovirus, human herpes virus–6 (HHV6), Epstein–Barr virus (EBV), adenovirus, polyomaviruses, human immunodeficiency virus in HSCT, respiratory viruses, and SARS-CoV2.
Dr. Sanjeet Singh Dadwal
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HSCT
- GVHD
- HHV6
- CMV
- Adenovirus
- BK and JC virus (polyomaviruses)
- HIV
- SARS-CoV2
- Chimeric antigen receptor therapy (CART)
- EBV